Craig Lindsley, PhD, co-director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD), has been named a fellow of the Royal Society of Chemistry and elected chair-elect of the Section of Pharmaceutical Sciences of the American Association for the Advancement of Science (AAAS).
Both distinguished positions acknowledge Lindsley’s significant contributions to pharmacology, therapeutics and the pharmaceutical sciences.
Lindsley is the William K. Warren Jr. Professor of Medicine, professor of Pharmacology and Biochemistry in Vanderbilt University School of Medicine and professor of Chemistry in the College of Arts and Science.
His one-year term as chair-elect of the Section of Pharmaceutical Sciences begins Feb. 20, after which he will serve a one-year term as chair.
Fellowship in the Royal Society of Chemistry is awarded to those who have held senior positions for more than five years and who have made an impact in the chemical sciences.
Lindsley helped pioneer development of drug-like compounds that, by adjusting the activity of receptors in the brain, may lead to new treatments for a wide range of brain disorders.
Recent awards include the 2017 Pharmacia-ASPET Award from the American Society for Pharmacology and Experimental Therapeutics and the 2018 Edward E. Smissman Lectureship from the University of Kansas. In December he was named the 2018 recipient of the Sato Memorial International Award by the Pharmaceutical Society of Japan.
